BHVN · NYSE · CIK 0001935979

Biohaven Ltd.

Biohaven Ltd.’s most recent SEC filing in our snapshot is a Form 8-K filed on Oct 22, 2026. Its EDGAR record lists 23 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2025
—
Net income, FY2025
-$738.8M
Form 4 filings on record, past 12 months
23

Company overview

Legal name (as filed)
Biohaven Ltd.
Ticker
BHVN
SEC Central Index Key (CIK)
0001935979
Industry (SIC)
Pharmaceutical Preparations (code 2834)
Business address
NEW HAVEN, CT
State or country of incorporation
Virgin Islands, British
Fiscal year ends
December 31
SEC filer category
Large accelerated filer
Position in SEC ticker list
#1900 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from Biohaven Ltd.’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue
n/aFY2021n/aFY2022n/aFY2023n/aFY2024n/aFY2025
Net income
-$213.8MFY2021-$570.3MFY2022-$408.2MFY2023-$846.4MFY2024-$738.8MFY2025
BHVN annual results
ItemFY2021
ended Dec 31, 2021		FY2022
ended Dec 31, 2022		FY2023
ended Dec 31, 2023		FY2024
ended Dec 31, 2024		FY2025
ended Dec 31, 2025
Revenue—————
Net income-$213.8M-$570.3M-$408.2M-$846.4M-$738.8M
Diluted EPS-$5.43-$12.75-$5.73-$9.28-$6.86
Total assets$142.1M$661.8M$513.2M$615.1M$451.4M
Cash and equivalents$76.1M$204.9M$248.4M$99.1M$230.0M

XBRL tags used: netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

BHVN latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Mar 2, 202610-KAnnual report· period Dec 31, 2025Document · Index
Aug 10, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Oct 22, 20268-KRegulation FD disclosure· period Oct 22, 2026Document · Index
Mar 13, 2026DEF 14ADefinitive proxy statement· period Apr 28, 2026Document · Index

Recent SEC filings

The 40 newest documents filed by or about Biohaven Ltd., by form type:

4 ×148-K ×123 ×210-Q ×2SCHEDULE 13G/A ×2SCHEDULE 13G ×1424B5 ×1S-3ASR ×1DEFA14A ×1DEF 14A ×14/A ×1S-8 ×110-K ×1
BHVN recent filings
FiledFormWhat it isOriginal
Oct 22, 20268-KRegulation FD disclosure· period Oct 22, 2026Document · Index
Oct 15, 20268-KMaterial agreement; Regulation FD disclosure· period Oct 8, 2026Document · Index
Sep 17, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 15, 2026Document · Index
Sep 10, 20268-KOther events· period Sep 4, 2026Document · Index
Aug 26, 20268-KMaterial agreement; Regulation FD disclosure· period Aug 26, 2026Document · Index
Aug 14, 20263Initial statement of beneficial ownership· period Aug 6, 2026Document · Index
Aug 14, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
Aug 10, 20268-KResults of operations· period Aug 10, 2026Document · Index
Aug 10, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Aug 7, 20268-KDirector or officer change· period Aug 3, 2026Document · Index
Jul 17, 20263Initial statement of beneficial ownership· period Jul 9, 2026Document · Index
Jul 9, 20268-KDirector or officer change· period Jul 9, 2026Document · Index
Jul 8, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
May 27, 20268-KRegulation FD disclosure· period May 26, 2026Document · Index
May 15, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
May 5, 20268-KOther events· period May 4, 2026Document · Index
May 4, 202610-QQuarterly report· period Mar 31, 2026Document · Index
May 4, 20268-KResults of operations· period May 4, 2026Document · Index
May 4, 20268-KShareholder vote results· period Apr 28, 2026Document · Index
May 4, 2026424B5424B5Document · Index
May 4, 2026S-3ASRSimplified registration statementDocument · Index
Apr 30, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 28, 2026Document · Index
Apr 30, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 28, 2026Document · Index
Apr 30, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 28, 2026Document · Index
Apr 30, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 28, 2026Document · Index
Apr 30, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 28, 2026Document · Index
Apr 30, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 28, 2026Document · Index
Apr 30, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 28, 2026Document · Index
Mar 19, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 17, 2026Document · Index
Mar 13, 2026DEFA14AAdditional proxy soliciting materialsDocument · Index
Mar 13, 2026DEF 14ADefinitive proxy statement· period Apr 28, 2026Document · Index
Mar 9, 20264/AStatement of changes in beneficial ownership (insider trade)· period Mar 4, 2025Document · Index
Mar 3, 20264Statement of changes in beneficial ownership (insider trade)· period Feb 27, 2026Document · Index
Mar 3, 20264Statement of changes in beneficial ownership (insider trade)· period Feb 27, 2026Document · Index
Mar 3, 20264Statement of changes in beneficial ownership (insider trade)· period Feb 27, 2026Document · Index
Mar 3, 20264Statement of changes in beneficial ownership (insider trade)· period Feb 27, 2026Document · Index
Mar 3, 20264Statement of changes in beneficial ownership (insider trade)· period Feb 27, 2026Document · Index
Mar 2, 20268-KResults of operations· period Mar 2, 2026Document · Index
Mar 2, 2026S-8Registration of employee benefit plan securitiesDocument · Index
Mar 2, 202610-KAnnual report· period Dec 31, 2025Document · Index

Insider filing activity

23 Form 4 filings appear in Biohaven Ltd.’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Pharmaceutical Preparations

All 194 companies in Pharmaceutical Preparations· Companies headquartered in Connecticut

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Electronics Plaud Note Pro AI Voice Recorder An AI voice recorder that turns earnings calls and meetings into notes. View on Amazon → Electronics Amazon Kindle Paperwhite Signature Edition 32GB Read investing classics and long reports without eye strain. View on Amazon → Electronics Apple 2026 MacBook Air 13-inch Laptop A lightweight laptop for spreadsheets and filing research. View on Amazon →

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0001935979 and XBRL company facts. Biohaven Ltd. on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.